Qualitative immunoassay for the detection of anti-SARS-COV-2 spike antibody in human milk samples.
Qualitative immunoassay for the detection of anti-SARS-COV-2 spike antibody in human milk samples.
复制标题
DOI:
10.1016/j.xpro.2022.101203
复制
发表时间:
2022-03-18
期刊:
影响因子:
--
通讯作者:
Powell RLR
中科院分区:
文献类型:
--
作者:
Yang X;Fox A;Powell RLR
Antibodies in milk obtained from those previously SARS-CoV-2-infected or vaccinated against COVID-19 may provide passive immunity to the breastfed infant. Few assays have been established to measure antibodies in human milk, despite the public health importance of this topic. In the present protocol, we describe an optimized indirect ELISA assay aimed to measure SARS-CoV-2-reactive antibodies in human milk, which can be used as a rapid screen on undiluted samples or to designate samples as relatively low, moderate, or high titer. For complete details on the use and execution of this protocol, please refer to. A protocol for measuring SARS-CoV-2-reactive antibodies in human milk Used to detect anti-Spike antibodies or those against other immunogens Can be used as a screening tool on undiluted milk Endpoint titer determination allows designation of relative potency of response Antibodies in milk obtained from those previously SARS-CoV-2-infected or vaccinated against COVID-19 may provide passive immunity to the breastfed infant. Few assays have been established to measure antibodies in human milk, despite the public health importance of this topic. In the present protocol, we describe an optimized indirect ELISA assay aimed to measure SARS-CoV-2-reactive antibodies in human milk, which can be used as a rapid screen on undiluted samples or to designate samples as relatively low, moderate, or high titer.